Valeant/Philidor execs convicted of multimillion dollar fraud
Regulator backs potential blockbuster ophthalmology drug
J&J taking on next gen drugs from Novartis, Eli Lilly, and Valeant.
Lanadelumab could revolutionise treatment of swelling disease.
Siliq will be cheaper than rivals from Novartis and Eli Lilly.
Patient groups slam pharma over drug costs in latest survey.
UK pharma also gets $130m payment from Valeant.
But drug will have boxed warning over suicidal ideation.